Morgan Lewis has received the Impact Deal of the Year Award from LMG Life Sciences in recognition of the firm’s representation of Merck in its exclusive $9.5 billion license and collaboration agreement with Kelun-Biotech to develop seven investigational preclinical antibody-drug conjugates for the treatment of cancer.
Now in its 11th year, the annual Americas Awards recognize top life sciences practitioners and law firms across a range of key practice areas—regulatory, intellectual property (IP), financial and corporate, and non-IP litigation and enforcement—and jurisdictions through a rigorous research process and interviews with leading lawyers from the field. Morgan Lewis partner David Glazer and associate Natalie Nicelli, along with partner Todd Liao, senior counsel Scott Kauffman, and associate Omobolaji Bedu, represented Merck in the transaction.
In addition to the Impact Deal of the Year Award, our firm and several of our lawyers are shortlisted in the following categories:
- Antitrust Firm of the Year
- Licensing & Collaboration Firm of the Year
- Venture Capital Firm of the Year
- General Patent Litigator of the Year – Midwest – Michael Abernathy
- General Patent Litigator of the Year – South – William Peterson
- Patent Strategy Attorney of the Year – Midwest – Christopher Betti
- Regulatory Attorney of the Year: FDA Medical Device – Dennis Gucciardo
- Venture Capital Attorney of the Year – Julio Vega
Original source can be found here.